Metformin and Vildagliptin

PubChem compound: 121488163

Therapeutic indications

Metformin and Vildagliptin is indicated for:

Type 2 diabetes mellitus

Population group: only adults (18 years old or older)

Metformin/vildagliptin combination is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:

  • in patients who are inadequately controlled with metformin hydrochloride alone.
  • in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets.
  • in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Metformin and Vildagliptin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: EUCREAS Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈